Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats
- PMID: 9450915
- DOI: 10.1089/oli.1.1997.7.575
Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats
Abstract
The aim of the present study is to evaluate the in vivo toxicologic effects of a phosphorothioate oligodeoxynucleotide (PS oligo) and three of its analogs [PS oligo containing four methylphosphonate linkages at the 3' and 5'-ends (MBO 1), PS oligo containing four 2'-O-methylribonucleosides at both the 3'- and 5'-ends (MBO 2), and PS oligo containing an 8 bp loop region at the 3'-end (self-stabilized oligo)]. Oligodeoxynucleotides were administrated intravenously to male and female rats at doses of 3, 10, and 30 mg/kg/day for 14 days. Rats were killed on day 15, blood samples were collected for hematology and clinical chemistry determinations, and tissues, including lymph nodes, spleens, livers, and kidneys, were subjected to pathologic examinations. The toxicity profiles of the four oligodeoxynucleotides were very similar, but differed in magnitude. In terms of the severity of the abnormalities caused by the oligodeoxynucleotides, the order was MBO 2 > PS oligo > self-stabilized oligo > MBO 1. Alterations in hematology parameters included thrombocytopenia, anemia, and neutropenia. Abnormalities in clinical chemistry parameters observed with PS oligo or MBO 2 were dose-dependent elevation of liver transaminases and reduction of the levels of alkaline phosphatase, albumin, and total protein. In addition, MBO 2 caused elevation of the total bilirubin level in male rats at the 30 mg/kg dose. No major alterations in hematology or clinical chemistry were observed in rats receiving MBO 1 or self-stabilized oligo. Dose-dependent enlargements of spleen, liver, and kidney were observed, especially in rats receiving PS oligo and MBO 2. Pathologic studies showed a generalized hyperplasia of the reticuloendothelial (RE) system in the tissues examined. Alterations in the spleen were mainly RE cell hyperplasia and hematopoietic cell proliferation. In addition to RE cell hyperplasia, lymph nodes showed necrosis, hepatocytes showed cytologic alterations and necrosis, and kidneys showed renal tubule regeneration. The severity of pathologic changes observed was oligodeoxynucleotide dependent, in the order of MBO 2 > PS oligo > self-stabilized oligo > MBO 1.
Similar articles
-
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288. Natl Toxicol Program Tech Rep Ser. 1994. PMID: 12595928
-
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340. Natl Toxicol Program Tech Rep Ser. 1993. PMID: 12616289
-
NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).Natl Toxicol Program Tech Rep Ser. 1997 Apr;450:1-321. Natl Toxicol Program Tech Rep Ser. 1997. PMID: 12594525
-
NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).Natl Toxicol Program Tech Rep Ser. 1993 Sep;423:1-336. Natl Toxicol Program Tech Rep Ser. 1993. PMID: 12616288
-
NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).Natl Toxicol Program Tech Rep Ser. 1993 Apr;414:1-284. Natl Toxicol Program Tech Rep Ser. 1993. PMID: 12616284
Cited by
-
The Evolution of Antisense Oligonucleotide Chemistry-A Personal Journey.Biomedicines. 2021 May 3;9(5):503. doi: 10.3390/biomedicines9050503. Biomedicines. 2021. PMID: 34063675 Free PMC article. Review.
-
Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703.Nucleic Acid Ther. 2015 Jun;25(3):130-40. doi: 10.1089/nat.2015.0533. Epub 2015 Mar 31. Nucleic Acid Ther. 2015. PMID: 25826686 Free PMC article.
-
Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities.Int J Nanomedicine. 2017 Dec 20;13:43-62. doi: 10.2147/IJN.S152141. eCollection 2018. Int J Nanomedicine. 2017. PMID: 29317815 Free PMC article.
-
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.Int J Nanomedicine. 2017 Jan 16;12:515-531. doi: 10.2147/IJN.S114477. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28144136 Free PMC article. Review.
-
Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1.J Pharmacol Exp Ther. 2015 Nov;355(2):329-40. doi: 10.1124/jpet.115.226969. Epub 2015 Sep 1. J Pharmacol Exp Ther. 2015. PMID: 26330536 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources